Published in J Gastroenterol on January 01, 2000
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci (2002) 1.02
Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci (2007) 0.95
The Expression of Murine Double Minute 2 (MDM2) on Helicobacter pylori-Infected Intestinal Metaplasia and Gastric Cancer. J Clin Biochem Nutr (2009) 0.86
Expression, purification and immuno-characteristics of recombination UreB protein of H.pylori. World J Gastroenterol (2001) 0.83
Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol (2005) 0.75
Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study). Gut (2009) 5.08
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. Endoscopy (2013) 2.76
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49
The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy (2005) 2.49
EndoResect study: endoscopic full-thickness resection of gastric subepithelial tumors. Endoscopy (2012) 2.44
Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy (2010) 2.11
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther (2009) 1.92
Miami classification for probe-based confocal laser endomicroscopy. Endoscopy (2011) 1.80
The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol (2001) 1.64
A comparison of Helicobacter pylori and H. heilmannii gastritis. A matched control study involving 404 patients. Scand J Gastroenterol (1997) 1.51
[S3-guidelines--sedation in gastrointestinal endoscopy]. Z Gastroenterol (2008) 1.47
[Helicobacter pylori and stomach carcinoma. Is a preventive intervention study of value?]. Pathologe (1998) 1.45
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole. Virchows Arch (1999) 1.40
Performance, patient acceptance, appropriateness of indications and potential influence on outcome of EUS: a prospective study in 397 consecutive patients. Gastrointest Endosc (1999) 1.40
An innovative, safe and sterile sigmoid access (ISSA) for NOTES. Endoscopy (2007) 1.39
NOTES for the cardia: antireflux therapy via transluminal access. Endoscopy (2010) 1.38
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer (1997) 1.18
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg (2008) 1.15
Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer (1999) 1.12
Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther (2007) 1.09
Confocal laser scanning fluorescence microscopy for in vivo determination of microvessel density in Barrett's esophagus. Endoscopy (2008) 1.09
Helicobacter heilmannii and gastric cancer. Lancet (1995) 1.09
Interobserver agreement and accuracy among international experts with probe-based confocal laser endomicroscopy in predicting colorectal neoplasia. Endoscopy (2010) 1.07
Transgastric in vivo histology in the peritoneal cavity using miniprobe-based confocal fluorescence microscopy in an acute porcine model. Endoscopy (2007) 1.06
Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc (2000) 1.05
The "ELITE" model: construct validation of a new training system for natural orifice transluminal endoscopic surgery (NOTES). Endoscopy (2009) 1.04
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1998) 0.99
Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology (2000) 0.98
Colorectal mini-de novo carcinoma: a reality in Germany too. Endoscopy (1995) 0.98
New classification for probe-based confocal laser endomicroscopy in the colon. Endoscopy (2011) 0.94
Euro-NOTES Status Paper: from the concept to clinical practice. Surg Endosc (2013) 0.92
Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia? Digestion (2000) 0.91
Natural orifice transluminal endoscopic surgery: cardiopulmonary safety of transesophageal mediastinoscopy. Endoscopy (2010) 0.91
Prospective study on bright lumen magnetic resonance colonography in comparison with conventional colonoscopy. Br J Radiol (2007) 0.90
Frequency of vacA genotypes and cytotoxin activity in Helicobacter pylori associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Clin Microbiol (1998) 0.88
Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study). Endoscopy (2012) 0.88
[Diagnosis of and therapy for gastric cancer--work-flow]. Zentralbl Chir (2009) 0.87
Effect of pneumoperitoneum on hemodynamics and inspiratory pressures during natural orifice transluminal endoscopic surgery (NOTES): an experimental, controlled study in an acute porcine model. Endoscopy (2007) 0.87
Multimodal endoscopic therapy for multifocal intraepithelial neoplasia and superficial esophageal squamous cell carcinoma - a case series. Endoscopy (2011) 0.87
Infected necrosis in severe pancreatitis--combined nonsurgical multi-drainage with directed transabdominal high-volume lavage in critically ill patients. Pancreatology (2009) 0.84
Training of a standardized natural orifice transluminal endoscopic surgery cholecystectomy using an ex vivo training unit. Endoscopy (2011) 0.84
True adenomas of the cardia: a case series of 3 patients. Digestion (2008) 0.83
[Changes in Helicobacter pylori gastritis caused by therapy with inhibitors of gastric acid secretion]. Z Gastroenterol (1999) 0.83
Microcirculation of subepithelial gastric tumors using contrast-enhanced ultrasound. Clin Hemorheol Microcirc (2010) 0.82
Gastritis associated with Crohn disease can be masked by Helicobacter pylori gastritis. Scand J Gastroenterol (1999) 0.82
Identifying persons at risk for gastric cancer? Helicobacter (1997) 0.81
Pathophysiology and pharmacological treatment of gastroesophageal reflux disease. Dig Dis (2000) 0.81
Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. Pathol Res Pract (1999) 0.81
Percutaneous endoscopic colostomy in a patient with chronic intestinal pseudo-obstruction and massive dilation of the colon. Endoscopy (2006) 0.80
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male. Z Gastroenterol (1998) 0.80
Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia. Cancer Gene Ther (2009) 0.80
Score card endoscopy: a multicenter study to evaluate learning curves in 1-week courses using the Erlangen Endo-Trainer. Endoscopy (2003) 0.79
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy. Eur J Gastroenterol Hepatol (1996) 0.79
Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease. Expert Opin Pharmacother (2001) 0.79
[Therapy of Buried Bumper Syndrome via NOTES - A Case Report]. Z Gastroenterol (2013) 0.78
[Prevention of stomach carcinoma by Helicobacter pylori eradication. Invitation to participate in the PRISMA Study]. Z Gastroenterol (1999) 0.78
Endoscopic measurement of Barrett's esophagus length is unreliable - a prospective comparative biopsy study. Z Gastroenterol (2004) 0.78
Natural-orifice transluminal endoscopic surgery: low-pressure pneumoperitoneum is sufficient and is associated with an improved cardiopulmonary response (PressurePig Study). Endoscopy (2011) 0.77
Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach. Pathol Res Pract (2000) 0.77
Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. Dis Esophagus (2008) 0.77
Fluorescein-enhanced autofluorescence imaging for accurate differentiation of neoplastic from non-neoplastic colorectal polyps: a feasibility study. Endoscopy (2011) 0.77
Natural orifice transluminal endoscopic surgery (NOTES). Endoscopy (2010) 0.77
A score card for upper GI endoscopy: Evaluation of interobserver variability in examiners with various levels of experience. Z Gastroenterol (2002) 0.77
[Endoscopic surgery through natural orifices (NOTES) in Germany: Status Report 2010]. Z Gastroenterol (2011) 0.76
Argon plasma coagulation of gastric inlet patches for the treatment of globus sensation: it is an effective therapy in the long term. Digestion (2013) 0.76
Pharmacologic management and treatment of gastroesophageal reflux disease. Dis Esophagus (2004) 0.76
Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment. BMC Gastroenterol (2002) 0.76
Cresyl violet as a fluorophore in confocal laser scanning microscopy for future in-vivo histopathology. Endoscopy (2003) 0.75
[Transgastric appendectomy--fiction or foresight?]. Z Gastroenterol (2007) 0.75
Reply to Qin and Linghu. Endoscopy (2013) 0.75
Training in GI endoscopy: can we objectively predict the performance of trainees? A prospective correlation study. Z Gastroenterol (2005) 0.75
[State of NOTES development in Germany: Status report of the D-NOTES-Congress 2011th]. Z Gastroenterol (2012) 0.75
A prospective multicenter clinical and endoscopic follow-up study of patients with gastroesophageal reflux disease. Z Gastroenterol (2005) 0.75
[Functional dyspepsia]. MMW Fortschr Med (2007) 0.75
[74-year-old patient with cystic pancreatic lesions. An endoscopy-based algorithm]. Internist (Berl) (2011) 0.75
[Helicobacter '98--epidemiology and significance in carcinogenesis]. Chirurg (1998) 0.75
Pill camera. Endoscopy (2010) 0.75
Endoscopic treatment of transcolonic misplacement of a percutaneous endoscopic gastrostomy tube. Endoscopy (2010) 0.75
Multimodal endoscopic therapy for multifocal intraepithelial neoplasia and superficial esophageal squamous cell carcinoma. Endoscopy (2012) 0.75
Hemodynamics after endoscopic submucosal injection of epinephrine in a porcine model. Endoscopy (2012) 0.75
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. Digestion (1998) 0.75
Changes in intra-abdominal pressure, hemodynamics, and peak inspiratory pressure during gastroscopy in a porcine model. Endoscopy (2007) 0.75
Long-term follow-up in patients with indeterminate Barrett esophagus. Digestion (2013) 0.75